Identification of epigenetically silenced genes in human pancreatic cancer by a novel method " microarray coupled with methyl-CpG targeted transcriptional activation" (MeTA-array)

Biochemical and Biophysical Research Communications

Volumn 411, Issue 1, 2011, Pages 162-167

  Shimizu, Hideyuki ^a   Horii, Akira ^a   Sunamura, Makoto ^a,b   Motoi, Fuyuhiko ^a   Egawa, Shinichi ^a   Unno, Michiaki ^a   Fukushige, Shinichi ^a,c  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO MEDICAL UNIVERSITY HACHIOJI MEDICAL CENTER   (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

DNA methylation; Epigenetics; MeTA array; Pancreatic cancer; Transcriptional repression; Tumor biomarkers

Indexed keywords

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CPG ISLAND; EPIGENETICS; GENE IDENTIFICATION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; METHYLATION; MICROARRAY ANALYSIS; MICROARRAY COUPLED WITH METHYL CPG TARGETED TRANSCRIPTIONAL ACTIVATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; UPREGULATION;

CELL LINE, TUMOR; CPG ISLANDS; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; NF-KAPPA B; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PANCREATIC NEOPLASMS; TRANSCRIPTIONAL ACTIVATION;

AGOUTI PACA;

EID: 79960563683     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.06.121     Document Type: Article

References (32)

1. Herman J.G., Baylin S.B. Gene silencing in cancer in association with promoter hypermethylation. N. Engl. J. Med. 2003, 349:2042-2054.
2. Sjöblom T., Jones S., Wood L.D., et al. The consensus coding sequences of human breast and colorectal cancers. Science 2006, 314:268-274.
3. Esteller M. Cancer epigenomics: DNA methylomes and histone-modification maps. Nat. Rev. Genet. 2007, 8:286-298.
4. Schuebel K.E., Chen W., Cope L., et al. Comparing the DNA hypermethylome with gene mutations in human colorectal cancer. PLoS Genet. 2007, 3:1709-1723.
5. Sinčić N., Herceg Z. DNA methylation and cancer: ghosts and angels above the genes. Curr. Opin. Oncol. 2011, 23:69-76.
6. Ballestar E., Wolffe A.P. Methyl-CpG-binding proteins. Targeting specific gene repression. Eur. J. Biochem. 2001, 268:1-6.
7. Fukushige S., Kondo E., Horii A. Methyl-CpG targeted transcriptional activation allows re-expression of tumor suppressor genes in human cancer cells. Biochem. Biophys. Res. Commun. 2008, 377:600-605.
8. Fukushige S., Kondo E., Horii A. Methyl-CpG targeted recruitment of p300 reactivates tumor suppressor genes in human cancer cells. Biochem. Biophys. Res. Commun. 2009, 379:1021-1026.
9. Gu Z., Inomata K., Ishizawa K., et al. The FBXW7 β-form is suppressed in human glioma cells. Biochem. Biophys. Res. Commun. 2007, 354:992-998.
10. Kondo E., Gu Z., Horii A., et al. The thymine DNA glycosylase MBD4 represses transcription and is associated with methylated p16INK4a and hMLH1 genes. Mol. Cell. Biol. 2005, 25:4388-4396.
11. Sato Y., Horii A., Fukushige S. Microarray coupled with methyl-CpG targeted transcriptional activation (MeTA-array) identifies hypermethylated genes containing the stringent criteria of CpG islands at high frequency. Epigenetics 2011, 6:752-759.
12. Sato N., Fukushima N., Maitra A., et al. Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays. Cancer Res. 2003, 63:3735-3742.
13. Mori Y., Shiwaku H., Fukushige S., et al. Alternative splicing of hMSH2 in normal human tissues. Hum. Genet. 1997, 99:590-595.
14. Ogawa K., Shiga K., Saijo S., et al. A novel G106D alteration of the SDHD gene in a pedigree with familial paraganglioma. Am. J. Med. Genet. A. 2006, 140:2441-2446.
15. Herman J.G., Graff J.R., Myöhänen S., et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA 1996, 93:9821-9826.
16. Takai D., Jones P.A. Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc. Natl. Acad. Sci. USA 2002, 99:3740-3745.
17. Fraga M.F., Ballestar E., Montoya G., et al. The affinity of different MBD proteins for a specific methylated locus depends on their intrinsic binding properties. Nucleic Acids Res. 2003, 31:1765-1774.
18. Meehan R.R., Lewis J.D., McKay S., et al. Identification of a mammalian protein that binds specifically to DNA containing methylated CpGs. Cell 1989, 58:499-507.
19. Lewis J.D., Meehan R.R., Henzel W.J., et al. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell 1992, 69:905-914.
20. Nair S.S., Coolen M.W., Stirzaker C., et al. Comparison of methyl-DNA immunoprecipitation (MeDIP) and methyl-CpG binding domain (MBD) protein capture for genome-wide DNA methylation analysis reveal CpG sequence coverage bias. Epigenetics 2011, 6:34-44.
21. Weber M., Davies J.J., Wittig D., et al. Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat. Genet. 2005, 37:853-862.
22. Rauch T., Li H., Wu X., et al. MIRA-assisted microarray analysis, a new technology for the determination of DNA methylation patterns, identifies frequent methylation of homeodomain-containing genes in lung cancer cells. Cancer Res. 2006, 66:7939-7947.
23. Soengas M.S., Capodieci P., Polsky D., et al. Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature 2001, 409:207-211.
24. Suzuki H., Gabrielson E., Chen W., et al. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat. Genet. 2002, 31:141-149.
25. Fuks F., Burgers W.A., Brehm A., et al. DNA methyltransferase Dnmt1 associates with histone deacetylase activity. Nat. Genet. 2000, 24:88-91.
26. Rountree M.R., Bachman K.E., Baylin S.B. DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci. Nat. Genet. 2000, 25:269-277.
27. Bachman K.E., Rountree M.R., Baylin S.B. Dnmt3a and Dnmt3b are transcriptional repressors that exhibit unique localization properties to heterochromatin. J. Biol. Chem. 2001, 276:32282-32287.
28. Lau W.L., Scholnick S.B. Identification of two new members of the CSMD gene family. Genomics 2003, 82:412-415.
29. Richter T.M., Tong B.D., Scholnick S.B. Epigenetic inactivation and aberrant transcription of CSMD1 in squamous cell carcinoma cell lines. Cancer Cell Int. 2005, 5:29.
30. Ma C., Quesnelle K.M., Sparano A., et al. Characterization CSMD1 in a large set of primary lung, head and neck, breast and skin cancer tissues. Cancer Biol. Ther. 2009, 8:907-916.
31. Fukushige S., Waldman F.M., Kimura M., et al. Frequent gain of copy number on the long arm of chromosome 20 in human pancreatic adenocarcinoma. Genes Chromosom. Cancer 1997, 19:161-169.
32. Kimura M., Abe T., Sunamura M., et al. Detailed deletion mapping on chromosome arm 12q in human pancreatic adenocarcinoma: identification of a 1-cM region of common allelic loss. Genes Chromosom. Cancer 1996, 17:88-93.